Fowler toasts Sohn legacy

Grounds, Fowler, and Weiss set up the Australian version, the Sohn Hearts & Minds conference in 2016, with the first meeting at the Sydney Opera House.
Guy Fowler & Chris Cuffe. Picture: Adam Yip

Glenda Korporaal

Fowler toasts Sohn legacy

January 25, 2024
Grounds, Fowler, and Weiss set up the Australian version, the Sohn Hearts & Minds conference in 2016, with the first meeting at the Sydney Opera House.
Read Transcript

In 2016 a group of three friends in the Sydney business community, then UBS chief executive Matthew Grounds, UBS chair of investment banking, Guy Fowler, and businessman Gary Weiss started the Australian version of the New York based Sohn conference.

Weiss had come back from a visit to the US, having seen the Sohn conference which was set up in 2006 in honour of the late Ira Sohn, a fund manager who died of cancer in his twenties, to raise money for cancer research.

The conference saw people pay thousands of dollars to hear a group of fund managers donating their time to give a stock tip.

Grounds, Fowler, and Weiss set up the Australian version, the Sohn Hearts & Minds conference in 2016, with the first meeting at the Sydney Opera House.

The conference has gone from strength to strength, raising many millions of dollars for medical research charities such as the Victor Chang Cardiac Research Institute.

Once the conference got going, Fowler had the idea of setting up a fund which could invest in the stock tips from the fund managers.

Set up in 2018, the Sohn Hearts and Minds Investment company, which is now listed on the ASX, supplements the revenue from the $3,500 a head conferences with some $8m a year from its earnings.

In total, the conferences and the fund have seen more than $65m going to medical research charities since 2016.

Fowler, who is now executive chair of investment bank Barrenjoey Capital Partners, has been awarded a Medal of the Order of Australia (OAM) in this year’s Australia Day honours for his “service to business and the community”.

“Our conference was unashamedly a copy of the Sohn conference in New York,” Fowler said in an interview with The Australian.

“It was my idea to do the fund to invest in the stocks which were being pitched at the conference. They were good ideas.

“It was an easy way for people to invest in ideas which were pitched at the conference without having to buy 20 different stocks.

“We said just buy this one … we raised about half a billion dollars.”

Managers investing the fund donate their services for free, with the money which would have been paid to investment managers going to medical research charities.

Fowler said the conference and the fund have helped to back some important medical research charities.

“Some of the medical research stories you hear at the conference absolutely blow your mind.

“It is absolutely extraordinary the research which is being done, including into cancer and depression.”

Mr Fowler said the Sohn Hearts & Minds conference was now a part of the annual corporate calendar in Australia, with the next event being held in Adelaide in November.

He said people were prepared to pay several thousand dollars to attend the annual conference because they felt they got value for money in listening to the ideas of world ranking fund managers which have included the late Charlie Munger, who appeared two years ago by video.

He said the establishment of the investment fund had been able to “supercharge” the earnings from the conference and deliver significantly more money for the medical research charities.

Asked his view of the outlook for investment banking in 2024, Mr Fowler said last year was a time when it was “tricky” to get deals done.

He said he didn’t see the outlook for IPOs this year “turning around too quickly”.

But, he said he felt there was a bit more activity around this year.

“Everyone talks up their own book, but it does feel like there is a bit of activity around.

“It doesn’t feel as bad as everyone says.

“Last year it was tricky to get things done, but there are still things happening and there still seems to be a reasonable level of activity about.”

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

In 2016 a group of three friends in the Sydney business community, then UBS chief executive Matthew Grounds, UBS chair of investment banking, Guy Fowler, and businessman Gary Weiss started the Australian version of the New York based Sohn conference.

Weiss had come back from a visit to the US, having seen the Sohn conference which was set up in 2006 in honour of the late Ira Sohn, a fund manager who died of cancer in his twenties, to raise money for cancer research.

The conference saw people pay thousands of dollars to hear a group of fund managers donating their time to give a stock tip.

Grounds, Fowler, and Weiss set up the Australian version, the Sohn Hearts & Minds conference in 2016, with the first meeting at the Sydney Opera House.

The conference has gone from strength to strength, raising many millions of dollars for medical research charities such as the Victor Chang Cardiac Research Institute.

Once the conference got going, Fowler had the idea of setting up a fund which could invest in the stock tips from the fund managers.

Set up in 2018, the Sohn Hearts and Minds Investment company, which is now listed on the ASX, supplements the revenue from the $3,500 a head conferences with some $8m a year from its earnings.

In total, the conferences and the fund have seen more than $65m going to medical research charities since 2016.

Fowler, who is now executive chair of investment bank Barrenjoey Capital Partners, has been awarded a Medal of the Order of Australia (OAM) in this year’s Australia Day honours for his “service to business and the community”.

“Our conference was unashamedly a copy of the Sohn conference in New York,” Fowler said in an interview with The Australian.

“It was my idea to do the fund to invest in the stocks which were being pitched at the conference. They were good ideas.

“It was an easy way for people to invest in ideas which were pitched at the conference without having to buy 20 different stocks.

“We said just buy this one … we raised about half a billion dollars.”

Managers investing the fund donate their services for free, with the money which would have been paid to investment managers going to medical research charities.

Fowler said the conference and the fund have helped to back some important medical research charities.

“Some of the medical research stories you hear at the conference absolutely blow your mind.

“It is absolutely extraordinary the research which is being done, including into cancer and depression.”

Mr Fowler said the Sohn Hearts & Minds conference was now a part of the annual corporate calendar in Australia, with the next event being held in Adelaide in November.

He said people were prepared to pay several thousand dollars to attend the annual conference because they felt they got value for money in listening to the ideas of world ranking fund managers which have included the late Charlie Munger, who appeared two years ago by video.

He said the establishment of the investment fund had been able to “supercharge” the earnings from the conference and deliver significantly more money for the medical research charities.

Asked his view of the outlook for investment banking in 2024, Mr Fowler said last year was a time when it was “tricky” to get deals done.

He said he didn’t see the outlook for IPOs this year “turning around too quickly”.

But, he said he felt there was a bit more activity around this year.

“Everyone talks up their own book, but it does feel like there is a bit of activity around.

“It doesn’t feel as bad as everyone says.

“Last year it was tricky to get things done, but there are still things happening and there still seems to be a reasonable level of activity about.”

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Jan 25, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 19, 2025

HM1 Leadership Restructure

The Board has announced the restructure of its leadership, transitioning from a full-time CEO role to a more streamlined model. As a result, Brett Jollie will step down as CEO and Richard Howes will be appointed to a new part-time role of Managing Director.

Read More
June 12, 2025

Coeur Mining – a high-conviction precious metals re-rating story

Coeur Mining provides access to precious metals production in politically stable jurisdictions, with potential for operational and valuation upside.

Read More
March 10, 2025

Reporting Season Insights: HM1 Core Portfolio Holdings

We spoke to our dedicated fund managers for an update on some of our major portfolio holdings following reporting season.

Read More
February 20, 2025

Significant increase in profit and increased fully franked dividend

We're pleased to declare an increased half-year fully franked dividend of 8.0 cents per share payable in April 2025.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
December 5, 2024

HM1 CEO Succession

Hearts and Minds Investments Limited advises that Paul Rayson intends to retire from the position of Chief Executive Officer, effective 19 February 2025.

Read More
Chris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John FederChris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John FederChris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John FederChris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John Feder
November 14, 2024

Sohn Hearts & Minds Investments fund targets $1.5bn valuation

‍Hearts & Minds Investments chair Chris Cuffe is hoping for HM1 to grow to more than $1.5bn in the next five years.

Read More
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 6, 2024

Exploring HM1 Top Stocks: Key Insights from Reporting Season

We have just come to the end of reporting season and the fund managers of our major portfolio holdings gave us their insights into the latest results of our key holdings.

Read More
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
March 7, 2024

Exploring HM1 Stocks: Key Insights from Reporting Season

We asked our fund managers for an update on how some of our key positions are performing off the back of the reporting season. Overall, it was a good period for the fund with some good moves to the upside.

Read More
February 6, 2024

Stock Story: ResMed

This month we take a deep dive into ResMed - one of the conference stocks within the fund that was astutely picked by Chris Kourtis of Ellerston Capital.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.